Summary
The folate receptor is a membrane linked glycoprotein that participates in the cellular accumulation of 5-methyltetrahydrofolic acid, methotrexate and 5,10-dideazatetrahydrofolic acid. Relative receptor overexpression has been observed in several malignant cell lines and tissues. In this study we determined receptor expression using western blot analysis in primary pediatrie malignancies involving the central nervous system. This study suggests that ependymoma tumors have a high frequency of receptor expression which may reflect a specific cytogenetic abnormality or the cellular origin of these tumors. The potential role in developing selective chemotherapy mediated by the folate receptor is also discussed.
Similar content being viewed by others
References
Andersen RGW, Kamen BA, Rothberg KG, Lacey SW: Potocytosis: sequestration and transport of small molecules by caveola. Science 255: 410–411, 1992
Ratnam M, Marquardt H, Duhring JL, Freisheim JH: Homologous membrane folate binding proteins in human placenta: Cloning and sequence of a cDNA. Biochemistry 28: 8249–8254, 1989
Page ST, Owen WC, Price K, Elwood PC: Expression of the human placental folate receptor transcript is regulated in human tissues. Organization and full nucleotide sequence of the gene. J Mol Biol 229:1175–1183, 1993
Brigle KE, Westin EH, Houghton MT, Goldman ID: Characterization of two cDNAs encoding folate-binding proteins from L1210 murine leukemia cells. J Biol Chem 266:17243–17249, 1991
Sadasivan E, Cedeno M, Rothenberg P: Genomic organization of the gene and a related pseudogene for a human binding protein. Biochem Biophys Acta 1131: 91–94, 1992
Matsue H, Rothberg KG, Takashima A, Kamen BA, Anderson RGW, Lacey SW: Folate receptor allows cells to grow in low concentrations of 5-methyltetrahydrofolate. Proc Natl Acad Sci 89: 6006–6009, 1992
Weitman SD, Lark RH, Coney LR, Fort DW, Frasca V, Zurawski VR, Kamen BA: Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 52: 3396–3401, 1992
Rothenberg SP, DaCosta M: Further observations on the folate binding factor in some leukemic cells. J Clin Invest 50: 719–726, 1971
Corrocher R, Pachor ML, Bambara LM, Stanzial AM, Biasi D, Sandre GD: Serum folate binding capacity in patients with solid tumors. Tumori 67:101–104, 1981
Willis SA, Lacey SW, Weitman SD, Kamen BA, Nisen PD: Folate receptor gene expression is tissue-specific and temporally-regulated. Cancer Ther Control 2: 223–230, 1992
Miotti S, Canevari S, Menard S, Mezzanzanica D, Porro G, Pupa SM, Regazzoni M, Tagliabue E, Colnaghi MI: Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor restricted specificity. Int J Cancer 39: 297–303, 1987
Alberti S, Miotti M, Fornaro M, Mantovani S, Canevari S, Menard S, Colnaghi ML: Xhe CA-MOv 18 molecule, a cellsurface marker of human ovarian carcinomas, is anchored to the cell membrane by phosphatidylinositol. Biochem Biophys Res Commun 17:1051–1055, 1990
Campbell IG, Jones T, Foulkes WD, Trowsdale J: High-affinity folate binding protein is a marker for ovarian cancer. Cancer Res 51:5329–5338, 1991
Weitman SD, Weinberg AG, Coney LR, Zurawski VR, Jennings DS, Kamen BA: Cellular localization of the folate receptor: Potential role in drug toxicity and folate homeostasis. Cancer Res 52: 6708–6711, 1992
Colman N, Herbert V: Folates and the nervous system. In: Blakley RL, Whitehead VM (eds) Folates and Pterins. John Wiley and Sons Inc., New York 339–357, 1986
Antony AC: The biological chemistry of folate receptors. Blood 79: 2807–2820, 1992
Pizzorno G, Cashmore AR, Moroson BA, Cross AD, Smith AK, Marling-Cason M, Kamen BA, Beardsley GP: 5,10-dideazatetrahydrofolic acid (DDATHF) transport in CCRFCEM and MA104 cell lines. J Biol Chem 268: 1017–1023, 1993
Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci 76:4350–4354, 1979
Zwiener RJ, Johnson CA, Anderson RGW, Kamen BA: Purified folate receptor-5-methyltetrahydrofolic acid interaction at neutral and acid pH. Cancer Res Ther Control 3:37–42, 1992
Kamen BA, Gaston JD: Properties of a folate binding protein (FBP) isolated from porcine kidney. Biochem Pharmacol 35: 2323–2329, 1986
Antony AC, Utley C, Van Horne KC, Kolhouse JF: Isolation and characterization of a folate receptor from human placenta. J Biol Chem 256: 9684–9692, 1984
Mihara Y, Matsukado Y, Goto S, Ushio Y, Tokumitsu S, Takahashi K: Monoclonal antibody against ependymoma-dedrived cell line. J Neuro-Oncol 12:1–11, 1992
Sainati L, Montaldi A, Putti MC, Giangaspero F, Rigobello L, Stella M, Zanesco L, Basso G: Cytogenetic t(11;17) (q13;21) in a pediatrie ependymoma. Cancer Genet Cytogenet 59: 213–216, 1992
Dal Cin P, Sandberg AA: Cytogenetic findings in a supratentorial ependymoma. Cancer Genet Cytogenet 30: 289–293, 1988
Berenson JR, Yang J, Mickle RA: Frequent amplification of thebcl-1 locus in head and neck squamous cell carcinomas. Oncogene 4: 1111–1116, 1989
Ali IU, Merlo G, Callahan R, Lidereau R: The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails thebcl-1, int-2 andhost loci. Oncogene 4: 89–92, 1989
Withers DA, Harvey RC, Faust JB, Melnyk O, Carey K, Meeker TC: Characterization of a candidatebcl-1 gene. Mol Cell Biol 11: 4846–4853, 1991
Mezzanzanica D, Garrido MA, Neblock DS, Daddona PE, Andrew SM, Zurawski VR, Segal DM, Wunderlich JR: Human T-lymphocytes targeted against an established human ovarian carcinoma with a bispecific F(ab')2 antibody prolong host survival in a murine xenograft model. Cancer Res 51:5716–5721, 1991
Jansen G, Schornagel JH, Westerhof GR, Rijksen G, Newell DR, Jackman AL: Multiple membrane transport systems for the uptake of folate-based thymidylate synthase inhibitors. Cancer Res 50: 7544–7548, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weitman, S.D., Frazier, K.M. & Kamen, B.A. The folate receptor in central nervous system malignancies of childhood. J Neuro-Oncol 21, 107–112 (1994). https://doi.org/10.1007/BF01052894
Issue Date:
DOI: https://doi.org/10.1007/BF01052894